on Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ)
Executive Board Restructuring at Eckert & Ziegler
Berlin, December 5, 2025. Eckert & Ziegler SE's Supervisory Board has announced a reduction in the size of its Executive Board from three to two members, effective January 1, 2026. The current contract of Frank Yeager, who oversees the Isotope Products segment, will conclude on December 31, 2025, as initially planned. Despite this change, Yeager will maintain a significant leadership role within the segment.
Following this restructuring, Dr. Harald Hasselmann will continue as Chairman of the Executive Board, with Dr. Gunnar Mann as a member. Eckert & Ziegler, part of the TecDAX index, specializes in isotope-related components for nuclear medicine and radiation therapy, offering comprehensive services and products in the radiopharmaceutical sector.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Eckert & Ziegler Strahlen- Und Medizintechnik AG news